Protein-Energy Malnutrition in Children and Adults: Marasmus vs Kwashiorkor, Diagnostics, and Phased Rehabilitation

Protein-energy malnutrition diverges into distinct phenotypic entities driven by divergent endocrinological adaptations:

• Marasmus (Caloric Wasting): Prompted by severe, balanced deprivation of both energy and protein. The neuroendocrine axis adapts via sustained cortisol output and low insulin, driving controlled lipolysis and somatic muscle proteolysis to preserve hepatic visceral protein synthesis. Features profound emaciation ('wizened elderly facies'), absent edema, and preserved serum albumin.
• Kwashiorkor (Dysadaptation and Edema): Precipitated by diets adequate in carbohydrates but severely lacking in essential amino acids. Hyperinsulinemia blocks peripheral amino acid mobilization, collapsing hepatic albumin output. Dropping plasma oncotic pressure triggers diffuse dependent edema and gross ascites.
• Hepatic Steatosis and Integumentary Pathology in Kwashiorkor: Impaired synthesis of apolipoprotein B-100 halts very-low-density lipoprotein (VLDL) export, trapping triglycerides in hepatocytes to produce massive hepatomegaly. Displays pathognomonic 'flaky-paint' dermatosis and hair depigmentation ('flag sign').
• Marasmic Kwashiorkor: Represents the worst prognostic tier, combining severe somatic tissue wasting with extensive pitting edema.

Standardized diagnostic screening protocols categorize severity to direct hospital admission:

• Mid-Upper Arm Circumference (MUAC): A validated rapid surrogate of muscle mass in children aged 6 to 59 months. MUAC < 115 mm designates Severe Acute Malnutrition (SAM), bearing severe mortality risk; readings between 115 and 125 mm denote Moderate Acute Malnutrition (MAM).
• WHO Standardized Growth Metrics: Weight-for-height Z-score (WHZ < -3 standard deviations) establishes acute wasting; height-for-age Z-score (HAZ < -2 SD) quantifies irreversible chronic linear stunting.
• Adult Laboratory Indices: Serum albumin (below 3.0 g/dL), serum prealbumin / transthyretin (below 15 mg/dL, reflecting short 48-hour synthetic turnover), and total lymphocyte count (TLC < 1,200/mcL reflecting thymic and lymphoid atrophy).
• GLIM Phenotypic Diagnostic Criteria: Unintentional weight loss exceeding 5% within 30 days or >10% within 180 days, combined with reduced BMI (below 18.5 kg/m2 in adults below 70 years, below 20 kg/m2 in seniors) and reduced muscle mass.

Therapeutic management of severe acute malnutrition must strictly adhere to the validated WHO three-phase algorithm:

• Phase I: Acute Stabilization (Days 1 to 7): Focuses entirely on treating hypoglycemia, hypothermia, dehydration, and silent sepsis while halting metabolic decay. Caloric delivery is capped using F-75 formula (75 kcal and 0.9 g protein/100 mL), featuring low sodium and reduced osmolarity to avert cardiac decompensation.
• Averting Refeeding and Free Radical Storms: High protein and sodium loads are strictly contraindicated during stabilization. Multivitamins, potassium, magnesium, zinc, and high-dose vitamin A are supplemented immediately. Supplemental iron is strictly prohibited during Phase I, as unbound iron fuels overwhelming sepsis.
• Phase II: Catch-Up Transition (Day 8 Onwards): Following edema resolution and return of appetite, calories are titrated upward using F-100 formula (100 kcal and 2.9 g protein/100 mL) or lipid-based Ready-to-Use Therapeutic Food (RUTF). Therapeutic iron is cautiously introduced to support catch-up erythropoiesis.
• Phase III: Community Rehabilitation and Convalescence: Transitioning to nutrient-dense local whole foods, sensory stimulation, and continued growth velocity surveillance.